Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, LP | Institution | 7.679.684 | 12,59% | US$ 882,93M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 6.945.813 | 11,39% | US$ 798,56M | 2026-03-31 |
| BlackRock, Inc. | Institution | 3.846.406 | 6,31% | US$ 442,22M | 2026-03-31 |
| Frazier Life Sciences IX, L.P. | Institution | 3.566.912 | 5,85% | US$ 410,09M | 2026-01-23 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 2.514.947 | 4,12% | US$ 289,14M | 2026-01-23 |
| Vanguard Capital Management, LLC | Institution | 2.414.776 | 3,96% | US$ 277,63M | 2026-03-31 |
| FMR LLC | Institution | 1.964.807 | 3,22% | US$ 225,89M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1.944.281 | 3,19% | US$ 223,53M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1.717.421 | 2,82% | US$ 197,45M | 2026-03-31 |
| BVF Partners L.P. | Institution | 1.584.727 | 2,60% | US$ 182,20M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1.432.083 | 2,35% | US$ 164,65M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 1.408.871 | 2,31% | US$ 161,98M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 1.334.809 | 2,19% | US$ 153,46M | 2026-03-31 |
| Novo Holdings A/S | Institution | 1.325.000 | 2,17% | US$ 152,34M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1.260.003 | 2,07% | US$ 144,86M | 2026-03-31 |
| Tang Capital Management, LLC | Institution | 1.236.027 | 2,03% | US$ 142,11M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 1.062.049 | 1,74% | US$ 122,10M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1.052.048 | 1,73% | US$ 120,95M | 2026-03-31 |
| BNP Paribas Financial Markets SNC | Institution | 911.419 | 1,49% | US$ 104,79M | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 811.294 | 1,33% | US$ 93,27M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 774.841 | 1,27% | US$ 89,08M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 772.595 | 1,27% | US$ 88,83M | 2025-09-30 |
| Capital Research and Management Company | Institution | 724.415 | 1,19% | US$ 83,29M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 710.938 | 1,17% | US$ 81,74M | 2026-03-31 |
| Bank of America Corporation | Institution | 676.624 | 1,11% | US$ 77,79M | 2026-03-31 |
| ClearBridge Investments, LLC | Institution | 671.870 | 1,10% | US$ 77,24M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 647.662 | 1,06% | US$ 74,46M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 625.000 | 1,02% | US$ 71,86M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 617.064 | 1,01% | US$ 70,94M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 610.666 | 1,00% | US$ 70,21M | 2025-09-30 |
| Renaissance Technologies LLC | Institution | 582.085 | 0,95% | US$ 66,92M | 2026-03-31 |
| BNY Asset Management | Institution | 579.179 | 0,95% | US$ 66,59M | 2026-03-31 |
| Woodline Partners LP | Institution | 567.894 | 0,93% | US$ 65,29M | 2026-03-31 |
| UBS Asset Management AG | Institution | 561.623 | 0,92% | US$ 64,57M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 547.306 | 0,90% | US$ 62,92M | 2026-03-31 |
| Frazier Life Sciences XI, L.P. | Institution | 544.954 | 0,89% | US$ 62,65M | 2026-01-23 |
| Balyasny Asset Management L.P. | Institution | 539.031 | 0,88% | US$ 61,97M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
